Short Interest in Ampliphi Biosciences Corp (APHB) Decreases By 2.5%
Ampliphi Biosciences Corp (NYSE:APHB) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 950,278 shares, a drop of 2.5% from the August 31st total of 974,681 shares. Approximately 11.1% of the company’s stock are short sold. Based on an average daily volume of 251,065 shares, the short-interest ratio is currently 3.8 days.
Shares of Ampliphi Biosciences Corp (NYSE:APHB) opened at 0.9348 on Tuesday. Ampliphi Biosciences Corp has a 1-year low of $0.67 and a 1-year high of $16.90. The stock’s market cap is $8.18 million. The company’s 50-day moving average is $0.85 and its 200 day moving average is $1.08.
TRADEMARK VIOLATION NOTICE: “Short Interest in Ampliphi Biosciences Corp (APHB) Decreases By 2.5%” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/03/short-interest-in-ampliphi-biosciences-corp-aphb-decreases-by-2-5.html.
Ampliphi Biosciences Corp Company Profile
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Stock Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related stocks with our FREE daily email newsletter.